Amperos Health, a New York-based AI-native platform for denial management and revenue recovery in healthcare, has raised $16 million in Series A funding.
Investors
The round was led by Bessemer Venture Partners, with participation from Uncork Capital and Neo.
Bessemer Venture Partners is a global venture capital firm that helps entrepreneurs lay strong foundations from inception to build long-standing companies. With more than 150 IPOs and over 420 portfolio companies across industries, Bessemer supports founders and CEOs from the seed stage through every phase of growth. The firm’s investment teams are located in San Francisco, Silicon Valley (Redwood City), New York, Boston, London, Bangalore, and Tel Aviv.
Amperos Health Use of Funds
The company will use the funding to accelerate growth, expand its analytics capabilities, and develop new AI-driven features across revenue cycle management workflows.
About Amperos Health
Led by CEO Michal Miernowski, Amperos Health is an AI-native denial management and revenue recovery solution designed specifically for healthcare providers to combat denials and streamline claims collections for revenue cycle management (RCM) teams. It automates end-to-end workflows for denial teams. Amperos uses state-of-the-art LLMs across voice, computer use, and more to complete entire collections workflows and maximize reimbursement at the lowest cost to collect. Headquartered in New York, Amperos serves over 3,000 clinical locations across all 50 states.
Funding Details
Company: Amperos Health, Inc.
Raised: $16.0M
Round: Series A
Funding Date: April 2026
Lead Investor: Bessemer Venture Partners
Additional Investors: Uncork Capital, Neo
Company Website: https://www.amperos.com/
Software Category: AI Healthcare / Revenue Cycle Management (RCM)
Source: https://www.prnewswire.com/news-releases/amperos-health-secures-16m-investment-as-it-launches-industrys-first-ai-native-denial-management-and-revenue-recovery-platform-302749446.html